News & Events - Nov 23rd, 2021
4Living Biotech and Sanofi sign a clinical collaboration agreement
4Living Biotech and Sanofi signed a clinical collaboration agreement. The two companies will join their expertise to demonstrate the potential efficacy of Mozobil® as a treatment for acute and chronic complications of COVID-19. Pascal Rigaudy, Global Head, Transplant Brands at Sanofi, mentioned that “Through its collaboration with 4P-Pharma, Sanofi is delighted to continue to advance&hellip